Entero Therapeutics, Inc. (ENTO) — Cash Flow Reinvestment Rate
Latest as of June 2014:
0.00x
Entero Therapeutics, Inc. (ENTO) has a Cash Flow Reinvestment Rate of 0.00x as of June 2014, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $129.24. See Entero Therapeutics, Inc. net asset quality index to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$129.24
USD
Capital Expenditures
$0.00
USD
Entero Therapeutics, Inc. Cash Flow Reinvestment Rate (2013–2013)
Historical reinvestment intensity for Entero Therapeutics, Inc. across 1 annual periods. Also explore Entero Therapeutics, Inc. assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Entero Therapeutics, Inc. (2013–2013)
Year-by-year capital reinvestment analysis for Entero Therapeutics, Inc.. For live market cap and broader valuation context, see ENTO market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.00x | $0.00 | $56.55 | $0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow